Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas

BACKGROUND: The aberrant expression of N-glycolyl GM3 ganglioside (NeuGcGM3) in patients with sarcomas was reevaluated by assessing the relation of this molecule with some clinicopathological features and overall survival (OS) of patients. METHODS: Fifty formalin-fixed and paraffin-embedded specimen...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Pilco-Janeta, Daniel, De la Cruz Puebla, Myriam, Soriano, Jorge, Osorio, Marta, Caballero, Iraida, Pérez, Adanays Calvo, Savon, Laynes, Cremades, Natalia, Blanco, Rancés, Carr, Adriana
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6558727/
https://ncbi.nlm.nih.gov/pubmed/31182063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5743-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires